Challenges Facing American Science: Funding Cuts and Immigration Restrictions

The past 18 months have marked a period of unprecedented disruption for American science, with federal policies targeting research funding, immigration and institutional budgets reshaping the landscape of scientific inquiry. While Congress later restored some funding, the cumulative impact on medical research, public health initiatives, and the global competitiveness of U.S. Science remains a critical concern. The challenges—ranging from grant cancellations to visa restrictions for foreign researchers—highlight deeper tensions over the role of science in policy, the future of academic collaboration, and the sustainability of long-term research investments.

At the heart of these developments is a broader question: How resilient is the scientific enterprise when faced with abrupt policy shifts, and what lessons can researchers, institutions, and policymakers draw from recent resistance efforts? Historian and political scientist Tim Snyder, whose work examines authoritarianism and the defense of democratic institutions, has framed these challenges as a test of collective action. His insights—shared in a recent interview with Science—offer a lens through which to understand how scientists and advocates have pushed back against restrictive measures, even as uncertainty lingers over their long-term effects.

Federal Funding and the Fragility of Research

The most immediate threat to American science has been the erosion of federal support. Reports indicate that some agencies faced proposals to slash budgets by as much as 60%, a figure that, if implemented, would have forced widespread program cancellations, layoffs, and delays in critical research. While Congress ultimately restored funding in subsequent appropriations, the instability created ripple effects across disciplines, from basic biomedical research to climate science. For health-related fields, this instability translates directly into slower progress on disease mechanisms, drug development, and public health preparedness.

One area of particular vulnerability is clinical and translational research, where long-term funding is essential for bridging the gap between laboratory discoveries and real-world applications. Interruptions in grant cycles can derail multi-year studies, particularly in areas like cancer immunotherapy, rare disease therapies, and infectious disease surveillance—all of which rely on sustained federal investment. The National Institutes of Health (NIH), the largest funder of biomedical research in the U.S., has historically been a bulwark against such disruptions, but even its stability is now in question.

Exacerbating these funding pressures is the restriction on immigration for foreign scientists and researchers. Visa policies that limit the entry of international talent—particularly in STEM fields—undermine the diversity of the scientific workforce, which has long been a strength of American research institutions. Many foreign researchers contribute to high-impact studies, collaborate on interdisciplinary projects, and bring perspectives that enrich innovation. When these pathways are constrained, the long-term consequences for medical research could include brain drain, reduced collaboration with global partners, and a narrowing of scientific inquiry.

Resistance and the Role of Scientists as Advocates

In response to these challenges, scientists have increasingly adopted strategies of resistance that go beyond traditional academic advocacy. Snyder’s work suggests that such resistance is most effective when it is organized, visible, and rooted in shared values—whether those values relate to the pursuit of knowledge, the protection of democratic norms, or the public good. In the context of science policy, this has taken the form of:

• Public mobilization: High-profile campaigns, such as open letters, petitions, and social media initiatives, have drawn attention to the threats facing research funding and immigration policies. These efforts have succeeded in rallying public and institutional support, though their long-term impact on policy remains uncertain.
• Legal challenges: Some researchers and advocacy groups have pursued legal avenues to contest restrictive policies, arguing that they violate constitutional principles or international agreements on academic freedom. While these cases are still unfolding, they represent a novel front in the defense of science.
• Institutional solidarity: Universities and research institutions have formed coalitions to lobby for policy changes, share resources, and provide legal and financial support to affected researchers. These networks have been crucial in mitigating immediate harm, though their sustainability depends on continued engagement.
• Alternative funding models: In anticipation of federal instability, some researchers have turned to private philanthropy, crowdfunding, and international collaborations to fill funding gaps. While these approaches offer short-term relief, they also raise questions about equity, long-term viability, and the potential for corporate influence over research priorities.

Snyder’s analysis underscores that resistance is not merely about reversing specific policies but about defending the broader ecosystem that enables scientific progress. This includes protecting the autonomy of researchers, ensuring transparency in decision-making, and maintaining public trust in science—a trust that has eroded in recent years due to politicization and misinformation.

Uncertainty and the Path Forward

Despite these efforts, significant uncertainties remain. Even after funding was restored, the damage to research momentum may take years to reverse. Early-career scientists, in particular, face precarious job prospects, with many forced to seek opportunities abroad or pivot to industry roles where funding is more secure but often less aligned with public health needs.

the global competitiveness of American science is at stake. Countries such as China, the European Union, and Canada have accelerated their own research investments in recent years, positioning themselves to lead in critical areas like AI-driven drug discovery, genomics, and pandemic preparedness. If U.S. Policies continue to create instability, the country risks ceding ground in these high-stakes fields.

Looking ahead, the resilience of American science will depend on several factors:

• Stable funding: Congress must prioritize predictable, long-term investments in research agencies, with safeguards against abrupt policy shifts.
• Immigration reform: Policies that facilitate the entry of foreign researchers—particularly those from countries with strong scientific traditions—will be essential for maintaining workforce diversity and innovation.
• Public engagement: Scientists and institutions must continue to communicate the value of research to the public, countering narratives that portray science as a luxury rather than a necessity for societal well-being.
• International collaboration: Strengthening partnerships with global research hubs can help offset domestic instability and ensure that American scientists remain at the forefront of discovery.

The lessons from this period are clear: Science does not exist in a vacuum. It is shaped by policy, politics, and public perception, and its future depends on the ability of researchers, institutions, and policymakers to work together in defense of evidence-based inquiry. As Snyder’s work reminds us, resistance is not a one-time act but an ongoing commitment—one that will determine whether American science emerges from this turbulence stronger or diminished.

For now, the scientific community stands at a crossroads. The choices made in the coming years will shape not only the trajectory of research but also the role of science in addressing the world’s most pressing challenges—from climate change to global health crises. The question is whether the lessons of resistance will translate into lasting change.